Saturday, February 4, 2023

Tag: Amarin

Free ‘Commercial Speech’ Cases Threaten Pharmaceutical Regulation

16
Two recent court rulings argue that pharmaceutical companies have a first amendment right to market drugs “off-label” with a lack of scientific evidence, threatening...